FDA has determined that a REMS is no longer necessary to ensure ERA medicines’ benefits outweigh the risk of EFT.
Similar Posts
STAQ Pharma of Ohio, LLC. Columbus, OH. 483 issued 05/16/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 05/16/2025
Short Title (70 char) STAQ Pharma of Ohio, LLC. Columbus, OH. 483 issued 05/16/2025
FEI Number 3025336457
Firm Name STAQ Pharma of Ohio, LLC
Record Type 483
State OH
Establishment Type Outsourcing FacRhino 69 Gummy may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Rhino 69 Gummy, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Sponsor Responsibilities – Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies
Sponsor Responsibilities – Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence StudiesZhejiang Huahai Pharmaceutical Co., Ltd. – 707145 – 06/06/2025
CGMP/Finished Pharmaceuticals/AdulteratedCertification Process for Designated Medical Gases
This guidance explains how FDA administers the certification process and describes the annual reporting requirements for designated medical gases (DMGs).Osteo Sin Max may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Osteo Sin Max, a product promoted and sold for joint pain on various websites, including ebay.com, and possibly in some retail stores.